Several laboratories show that it is feasible to design potent, nonpeptide, drug-like, small molecules, which inhibit protein protein interactions.
House sparrows -- ubiquitous, dust-colored, one-ounce crumb-snatchers -- are probably a principal reservoir here; new tests at federal laboratories show they can harbor the virus for five days or more at levels high enough to infect mosquitoes that bite them.
The results of the subjective tests performed in two different laboratories show high consistency and correlation.
Moreover, promising systemic effects reported recently by independent laboratories show that the PDT of cancer in different animal models induce an activation of systemic long-term memory T-cells and thereby have tumor-vaccinating effects [42].
Similarly, the results obtained by the laboratories show that the quality of samples was not a limitation in the EQA.
Expression data reported from other laboratories show that almEFG is upregulated during early stages of V. cholerae infection in human volunteers and mouse infection models.
